scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...627739P |
P356 | DOI | 10.1371/JOURNAL.PONE.0027739 |
P932 | PMC publication ID | 3218024 |
P698 | PubMed publication ID | 22110749 |
P5875 | ResearchGate publication ID | 51824288 |
P50 | author | Eun-Jung Park | Q88848206 |
P2093 | author name string | Sangdun Choi | |
Hyuk-Kwon Kwon | |||
Gwang Lee | |||
Sun A Kim | |||
Yong-Min Choi | |||
Wooyoung Shim | |||
P2860 | cites work | MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption | Q81464707 |
Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis | Q84115705 | ||
STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria | Q46082397 | ||
Modulation of osteoclastogenesis by fatty acids | Q46490345 | ||
A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model | Q46864205 | ||
Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. | Q50800975 | ||
Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. | Q51604397 | ||
Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. | Q52562535 | ||
Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. | Q53565120 | ||
Inhibition of Nitric Oxide Synthase Blocks Osteoclastic Bone Resorption in Adaptive Bone Modeling | Q58145727 | ||
Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism | Q73191511 | ||
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand | Q73211247 | ||
Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption | Q73251559 | ||
Nitric oxide is a regulator of bone remodelling | Q73718709 | ||
Essential fatty acids and osteoporosis | Q73740493 | ||
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL) | Q73907464 | ||
A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss | Q79240430 | ||
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications | Q24806684 | ||
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR | Q28144113 | ||
Nitric oxide synthases: structure, function and inhibition | Q28207668 | ||
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation | Q28236005 | ||
Functional interactions between Stat5 and the glucocorticoid receptor | Q28294034 | ||
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
Nitric oxide and bone | Q28343869 | ||
Osteoclast differentiation and activation | Q29547556 | ||
The molecular basis of osteoclast differentiation and activation | Q34201145 | ||
Jaks, STATs, Cytokines, and Sepsis | Q34987949 | ||
Inhibition of lipopolysaccharide‐inducible nitric oxide synthase, TNF‐α and COX‐2 expression by sauchinone effects on I‐κBα phosphorylation, C/EBP and AP‐1 activation | Q35045262 | ||
Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease | Q35057480 | ||
Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption | Q35174052 | ||
Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase | Q35183474 | ||
Regulation of the expression of inducible nitric oxide synthase. | Q35605774 | ||
Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells | Q35821780 | ||
Modulation of osteoclast formation | Q36032112 | ||
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase | Q38311029 | ||
An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide | Q38349380 | ||
Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3. | Q39993181 | ||
Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells | Q40114184 | ||
Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan | Q40195873 | ||
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling | Q40279586 | ||
Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. | Q40809918 | ||
STATs: signal transducers and activators of transcription | Q40974978 | ||
Differential use of CREB binding protein-coactivator complexes | Q41064392 | ||
Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines | Q41120279 | ||
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis | Q44209334 | ||
Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion | Q44341875 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e27739 | |
P577 | publication date | 2011-11-16 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Capric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis | |
P478 | volume | 6 |
Q34092086 | A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts |
Q21134602 | Anti-inflammatory activities of inotilone from Phellinus linteus through the inhibition of MMP-9, NF-κB, and MAPK activation in vitro and in vivo |
Q92354216 | Anti-osteoclastogenic effect of epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo |
Q35691436 | Canine mammary cancer cells direct macrophages toward an intermediate activation state between M1/M2. |
Q92277418 | Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB-NFATc1 signal pathway |
Q39304006 | Evidence for mitoxantrone-induced block of inwardly rectifying K(+) channels expressed in the osteoclast precursor RAW 264.7 cells differentiated with lipopolysaccharide |
Q57074587 | Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy |
Q36543680 | Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration |
Q50016514 | LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis |
Q40364616 | Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33. |
Q92538377 | More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis |
Q35548822 | Morphological and proteomic analyses reveal that unsaturated guluronate oligosaccharide modulates multiple functional pathways in murine macrophage RAW264.7 cells. |
Q40309601 | Neocryptotanshinone inhibits lipopolysaccharide-induced inflammation in RAW264.7 macrophages by suppression of NF-κB and iNOS signaling pathways |
Q34807106 | Photobiomodulation induced by 670 nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress |
Q91662693 | Therapeutic potentials and modulatory mechanisms of fatty acids in bone |
Q42496287 | Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function. |
Search more.